ERBB2 and neoplasm: Human epidermal growth factor receptor 2 (HER2) over-expression in cancer patients is a genetic alteration that promotes cancer cell proliferation and survival, resulting in increased tumor growth and poor clinical outcome in the absence of HER2 targeted therapy [1, 2].